{"type":"answer","id":230938,"parentType":"question","parentId":22902,"uid":27926,"contents":"按照3M自己的數據分析結論，有理由認可執行美國NIOSH-42CFR84標準的N95和執行中國GB2626-2006標準的KN95在過濾生物氣凝膠微粒（如病毒）方面是<b>對等的（equivalent）</b>產品。<br>\n<blockquote>Based on this comparison, it is reasonable to consider China KN95, AS/NZ P2, Korea 1st Class, and Japan DS FFRs as <b>“equivalent”</b> to US NIOSH N95 and European FFP2 respirators, for filtering non-oil-based particles such as those resulting from wildfires, PM 2.5 air pollution, volcanic eruptions, or<b> bioaerosols (e.g. viruses)</b>.</blockquote><br>\n文件來源：<a href=\"https://multimedia.3m.com/mws/media/1791500O/comparison-ffp2-kn95-n95-filtering-facepiece-respirator-classes-tb.pdf\" rel=\"nofollow noreferrer noopener\" target=\"_blank\">https://multimedia.3m.com/mws/media/1791500O/comparison-ffp2-kn95-n95-filtering-facepiece-respirator-classes-tb.pdf</a><br>\n<br>\n考慮到競爭對手之間本應該有的利益衝突，這段對對手的肯定我認爲是比較有可信度的。<br>\n<br>\n因此，FDA 在口罩短缺的緊要關頭對KN95 進行限制著實讓人費解。無論中美貿易戰和知識產權紛爭進展如何，在人命關天的時候不優先考慮保護本國人的生命，這在政治上已經輸了一籌。","date":"2020-04-06","agreeCount":2,"discussionCount":1}